Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
2.
Antimicrob Agents Chemother ; 52(11): 4043-9, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18809946

RESUMEN

Fluconazole is being increasingly used to prevent and treat invasive candidiasis in neonates, yet dosing is largely empirical due to the lack of adequate pharmacokinetic (PK) data. We performed a multicenter population PK study of fluconazole in 23- to 40-week-gestation infants less than 120 days of age. We developed a population PK model using nonlinear mixed effect modeling (NONMEM) with the NONMEM algorithm. Covariate effects were predefined and evaluated based on estimation precision and clinical significance. We studied fluconazole PK in 55 infants who at enrollment had a median (range) weight of 1.02 (0.440 to 7.125) kg, a gestational age at birth (BGA) of 26 (23 to 40) weeks, and a postnatal age (PNA) of 2.3 (0.14 to 12.6) weeks. The final data set contained 357 samples; 217/357 (61%) were collected prospectively at prespecified time intervals, and 140/357 (39%) were scavenged from discarded clinical specimens. Fluconazole population PK was best described by a one-compartment model with covariates normalized to median values. The population mean clearance (CL) can be derived for this population by the equation CL (liter/h) equals 0.015 . (weight/1)(0.75) . (BGA/26)(1.739) . (PNA/2)(0.237) . serum creatinine (SCRT)(-4.896) (when SCRT is >1.0 mg/dl), and using a volume of distribution (V) (liter) of 1.024 . (weight/1). The relative standard error around the fixed effects point estimates ranged from 3 to 24%. CL doubles between birth and 28 days of age from 0.008 to 0.016 and from 0.010 to 0.022 liter/kg/h for typical 24- and 32-week-gestation infants, respectively. This population PK model of fluconazole discriminated the impact of BGA, PNA, and creatinine on drug CL. Our data suggest that dosing in young infants will require adjustment for BGA and PNA to achieve targeted systemic drug exposures.


Asunto(s)
Antifúngicos/farmacocinética , Fluconazol/farmacocinética , Factores de Edad , Algoritmos , Antifúngicos/administración & dosificación , Antifúngicos/sangre , Candidiasis/sangre , Candidiasis/tratamiento farmacológico , Candidiasis/prevención & control , Creatinina/sangre , Relación Dosis-Respuesta a Droga , Femenino , Fluconazol/administración & dosificación , Fluconazol/sangre , Humanos , Lactante , Recién Nacido , Recien Nacido Prematuro , Masculino , Tasa de Depuración Metabólica , Modelos Biológicos , Método de Montecarlo , Dinámicas no Lineales , Estudios Prospectivos
3.
J Perinatol ; 28(10): 696-701, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18596711

RESUMEN

OBJECTIVE: To determine the frequency and risk factors for clinic and pharmacy use in preterm infants during the first year after neonatal intensive care unit (NICU) discharge. STUDY DESIGN: We analyzed clinic visits and prescriptions in a cohort of 23 to 32 weeks infants. We constructed multivariable regression models to determine risk factors for high use. RESULT: The 892 preterm infants experienced 18 346 pediatric visits (mean 20 visits per infant per year) and filled 2100 prescriptions (mean 5.5 prescriptions per year among infants taking medications). Most visits were non-well child care visits to pediatric primary care providers. Prematurity and bronchopulmonary dysplasia (BPD) are important risk factors: infants at 23 to 26 weeks gestation or infants with BPD had an average 29 visits per year and 9 prescriptions per year among infants taking medication. However, half of the highest using infants were relatively healthy infants at 27 to 32 weeks gestation who escaped BPD, NEC or grade 3 to 4 intraventricular hemorrhage. CONCLUSION: Premature infants had frequent pediatric visits and prescription medications. Extreme prematurity and neonatal morbidities are important risk factors; however, half of the highest using infants are moderately preterm without neonatal morbidities.


Asunto(s)
Enfermedades del Prematuro/terapia , Cuidado Intensivo Neonatal , Visita a Consultorio Médico/estadística & datos numéricos , Medicamentos bajo Prescripción/uso terapéutico , Atención Ambulatoria/estadística & datos numéricos , Estudios de Cohortes , Femenino , Humanos , Lactante , Recién Nacido , Recien Nacido Prematuro , Masculino , Alta del Paciente , Servicios Farmacéuticos/estadística & datos numéricos , Estudios Retrospectivos , Factores de Riesgo
4.
J Perinatol ; 28(3): 233-4, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18309318

RESUMEN

We report two infants treated with daptomycin for methicillin-resistant Staphylococcus aureus infection and describe peak and trough blood concentrations measured during therapy. The peak concentrations were 41.7 and 36.7 mcg ml(-1), and the 12-hour trough concentrations were 12.7 and 16.3 mcg ml(-1), respectively. Even though the infants received higher doses than adults, their drug concentrations were comparable to those observed in adults treated with regular dosing of daptomycin.


Asunto(s)
Antibacterianos/farmacocinética , Bacteriemia/tratamiento farmacológico , Daptomicina/farmacocinética , Resistencia a la Meticilina/efectos de los fármacos , Infecciones Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus/efectos de los fármacos , Bacteriemia/microbiología , Monitoreo de Drogas/métodos , Humanos , Lactante , Recién Nacido , Recien Nacido Prematuro , Staphylococcus aureus/patogenicidad
6.
J Comput Assist Tomogr ; 11(4): 698-700, 1987.
Artículo en Inglés | MEDLINE | ID: mdl-3597896

RESUMEN

Origin of the right pulmonary artery from the ascending aorta is a rare congenital malformation resulting in a large left-to-right shunt through the right lung at systemic pressure. We report the CT findings in an adult with this anomaly. Computed tomography was diagnostic. The patient is the sixth adult with this condition reported in the literature.


Asunto(s)
Arteria Pulmonar/anomalías , Tomografía Computarizada por Rayos X , Adulto , Humanos , Masculino , Arteria Pulmonar/diagnóstico por imagen
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA